Aceclidine Hydrochloride Patent Expiration

Aceclidine Hydrochloride was first introduced by Lenz Therapeutics Inc in its drug Vizz on Jul 31, 2025.


Aceclidine Hydrochloride Patents

Given below is the list of patents protecting Aceclidine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Vizz US12128036 Oct 08, 2039 Lenz Therap
Vizz US10052313 Mar 24, 2034 Lenz Therap
Vizz US11179328 Mar 24, 2034 Lenz Therap
Vizz US9844537 Mar 24, 2034 Lenz Therap



Aceclidine Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Aceclidine Hydrochloride Generic API Manufacturers

Given below is the list of companies who have filed for Aceclidine Hydrochloride generic, along with the locations of their manufacturing plants worldwide.